Methyl-1-testosterone
 | This article relies largely or entirely on a single source. (May 2022) |
 | |
| Clinical data | |
|---|---|
| Other names | M1T; SC-11195; Methyldihydroboldenone; 17α-Methyl-1-testosterone; 17α-Methyl-4,5α-dihydro-δ1-testosterone; 17α-Methyl-δ1-DHT; 17α-Methyl-5α-androst-1-en-17β-ol-3-one |
| Routes of administration | By mouth |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.219.594 |
| Chemical and physical data | |
| Formula | C20H30O2 |
| Molar mass | 302.458 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Methyl-1-testosterone (M1T; developmental code name SC-11195), also known as 17α-methyl-4,5α-dihydro-δ1-testosterone (17α-methyl-δ1-DHT) or 17α-methyl-5α-androst-1-en-17β-ol-3-one, as well as methyldihydroboldenone, is a synthetic and orally active anabolic–androgenic steroid (AAS)[1] which was never marketed for medical use. It is the 17α-methyl derivative of 1-testosterone (Δ1-DHT; dihydroboldenone).
Methyl-1-testosterone is on the World Anti-Doping Agency's list of prohibited substances,[2] and is therefore banned from use in most major sports.
References
[edit]- ^ Parr MK, Blatt C, Zierau O, Hess C, Gütschow M, Fusshöller G, Opfermann G, Schänzer W, Diel P (December 2011). "Endocrine characterization of the designer steroid methyl-1-testosterone: investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism". Endocrinology. 152 (12): 4718–28. doi:10.1210/en.2011-1164. PMID 21990312.
- ^ "The World Anti-Doping Code: The 2012 Prohibited List" (PDF). World Anti-Doping Agency. Archived from the original (PDF) on 2012-05-13. Retrieved 2012-07-17.
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |